Estimation of the Antirelapse Efficacy of Tafenoquine, Using Plasmodium vivax Genotyping

Prevention of relapse of Plasmodium vivax infection is a key treatment goal in malaria. Use of P. vivax genotyping in a multicenter, double-blind, randomized, placebo-controlled phase 2b study in Peru, India, Thailand, and Brazil allowed determination of genetically heterologous or homologous P. viv...

Descripción completa

Detalles Bibliográficos
Autores principales: Beck, Hans-Peter, Wampfler, Rahel, Carter, Nick, Koh, Gavin, Osorio, Lyda, Rueangweerayut, Ronnatrai, Krudsood, Srivcha, Lacerda, Marcus V., Llanos-Cuentas, Alejandro, Duparc, Stephan, Rubio, Justin P., Green, Justin A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Major Articles and Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747625/
https://www.ncbi.nlm.nih.gov/pubmed/26500351
http://dx.doi.org/10.1093/infdis/jiv508

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747625/
https://www.ncbi.nlm.nih.gov/pubmed/26500351
http://dx.doi.org/10.1093/infdis/jiv508

Ejemplares similares